{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:28:56Z","timestamp":1793500136558,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170205"],"award-info":[{"award-number":["82170205"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jtct.2025.07.012","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T17:07:22Z","timestamp":1754413642000},"page":"918.e1-918.e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["NUP98 Rearrangement Dynamics Predict Outcomes in Adult Patients With Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Real-World Study"],"prefix":"10.1016","volume":"31","author":[{"given":"Xiaolin","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengli","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kourong","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guifang","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7051-219X","authenticated-orcid":false,"given":"Yi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.jtct.2025.07.012_bib0001","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1182\/blood.2020007093","article-title":"Mechanistic insights and potential therapeutic approaches for NUP98-rearranged hematologic malignancies","volume":"136","author":"Michmerhuizen","year":"2020","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.jtct.2025.07.012_bib0002","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1182\/blood-2011-07-328880","article-title":"NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights","volume":"118","author":"Gough","year":"2011","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jtct.2025.07.012_bib0003","doi-asserted-by":"crossref","DOI":"10.1002\/hem3.70013","article-title":"NUP98 oncofusions in myeloid malignancies: an update on molecular mechanisms and therapeutic opportunities","volume":"8","author":"Rasouli","year":"2024","journal-title":"Hemasphere"},{"issue":"2","key":"10.1016\/j.jtct.2025.07.012_bib0004","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng0296-154","article-title":"Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia","volume":"12","author":"Nakamura","year":"1996","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.jtct.2025.07.012_bib0005","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/ng0296-159","article-title":"The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9","volume":"12","author":"Borrow","year":"1996","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.jtct.2025.07.012_bib0006","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.3324\/haematol.2022.281653","article-title":"Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia","volume":"108","author":"Bertrums","year":"2023","journal-title":"Haematologica"},{"issue":"19","key":"10.1016\/j.jtct.2025.07.012_bib0007","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1182\/bloodadvances.2024012960","article-title":"NUP98 is rearranged in 5.0% of adult East Asian patients with AML","volume":"8","author":"Kim","year":"2024","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.jtct.2025.07.012_bib0008","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/leu.2016.267","article-title":"NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis","volume":"31","author":"Struski","year":"2017","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.jtct.2025.07.012_bib0009","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00277-022-05047-8","article-title":"Acute myeloid leukemia patients with NUP98::NSD1 showing initially poor treatment response can benefit from FLT3 inhibitors and venetoclax as well as HSCT","volume":"102","author":"Sun","year":"2023","journal-title":"Ann Hematol"},{"issue":"11","key":"10.1016\/j.jtct.2025.07.012_bib0010","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1182\/bloodadvances.2023012479","article-title":"Identification of novel NUP98 fusion partners and comutations in acute myeloid leukemia: an adult cohort study","volume":"8","author":"Heald","year":"2024","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.jtct.2025.07.012_bib0011","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3390\/onco3030011","article-title":"NUP98 Rearrangements in AML: Molecular Mechanisms and Clinical Implications","volume":"3","author":"Mohanty","year":"2023","journal-title":"Onco"},{"issue":"4","key":"10.1016\/j.jtct.2025.07.012_bib0012","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/leu.2016.361","article-title":"NUP98-fusion transcripts characterize different biological entities within acute myeloid leukemia: a report from the AIEOP-AML group","volume":"31","author":"Bisio","year":"2017","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.jtct.2025.07.012_bib0013","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"Suppl 2","key":"10.1016\/j.jtct.2025.07.012_bib0014","first-page":"5","article-title":"Measurable residual disease monitoring in AML: Prospects for therapeutic decision-making and new drug development","volume":"100 Suppl 2","author":"Short","year":"2024","journal-title":"Am J Hematol"},{"issue":"14","key":"10.1016\/j.jtct.2025.07.012_bib0015","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1182\/bloodadvances.2022009493","article-title":"Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML\/MDS","volume":"7","author":"Loke","year":"2023","journal-title":"Blood Advances"},{"key":"10.1016\/j.jtct.2025.07.012_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217264","article-title":"Consensus on the monitoring, treatment, and prevention of leukaemia relapse after allogeneic haematopoietic stem cell transplantation in China: 2024 update","volume":"605","author":"Wang","year":"2024","journal-title":"Cancer Lett"},{"issue":"26","key":"10.1016\/j.jtct.2025.07.012_bib0017","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1182\/blood.2021013626","article-title":"2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party","volume":"138","author":"Heuser","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtct.2025.07.012_bib0018","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13045-021-01159-2","article-title":"The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update","volume":"14","author":"Zhang","year":"2021","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.jtct.2025.07.012_bib0019","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13045-018-0564-x","article-title":"The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology","volume":"11","author":"Xu","year":"2018","journal-title":"J Hematol Oncol"},{"issue":"12","key":"10.1016\/j.jtct.2025.07.012_bib0020","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jtct.2025.07.012_bib0021","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/bmt.2009.359","article-title":"Regression modeling of competing risk using R: an in depth guide for clinicians","volume":"45","author":"Scrucca","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2025.07.012_bib0022","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41408-024-01066-y","article-title":"The landscape of NUP98 rearrangements clinical characteristics and treatment response from 1491 acute leukemia patients","volume":"14","author":"Tian","year":"2024","journal-title":"Blood Cancer J"},{"issue":"13","key":"10.1016\/j.jtct.2025.07.012_bib0023","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1182\/blood-2011-04-346643","article-title":"NUP98\/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern","volume":"118","author":"Hollink","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtct.2025.07.012_bib0024","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/HS9.0000000000000031","article-title":"Molecular Profiling Defines Distinct Prognostic Subgroups in Childhood AML: A Report From the French ELAM02 Study Group","volume":"2","author":"Marceau-Renaut","year":"2018","journal-title":"Hemasphere"},{"issue":"3","key":"10.1016\/j.jtct.2025.07.012_bib0025","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/leu.2012.249","article-title":"Analysis of NUP98\/NSD1 translocations in adult AML and MDS patients","volume":"27","author":"Thol","year":"2013","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.jtct.2025.07.012_bib0026","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/s41409-023-02030-3","article-title":"Allogeneic stem cell transplantation can prolong the survival of patients with NUP98-rearranged acute myeloid leukemia","volume":"58","author":"Shen","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jtct.2025.07.012_bib0027","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/s41409-023-02106-0","article-title":"Allogeneic hematopoietic stem cell transplantation for adult acute myeloid leukemia patients with nucleoporin 98 (NUP98) gene rearrangements: a real-world study in China","volume":"58","author":"Cao","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2025.07.012_bib0028","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.3324\/haematol.2013.100917","article-title":"Potent co-operation between the NUP98-NSD1 fusion and the FLT3-ITD mutation in acute myeloid leukemia induction","volume":"99","author":"Thanasopoulou","year":"2014","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.jtct.2025.07.012_bib0029","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/s41375-023-01913-0","article-title":"NUP98::Nsd1 and FLT3-ITD collaborate to generate acute myeloid leukemia","volume":"37","author":"Matsukawa","year":"2023","journal-title":"Leukemia"},{"issue":"15","key":"10.1016\/j.jtct.2025.07.012_bib0030","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1182\/blood-2014-04-570929","article-title":"NUP98\/NSD1 and FLT3\/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report","volume":"124","author":"Ostronoff","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jtct.2025.07.012_bib0031","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/bjh.19962","article-title":"Landscape of somatic mutations and clonal evolution in NUP98-rearranged adult acute myeloid leukaemia","volume":"206","author":"Frerich","year":"2024","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.jtct.2025.07.012_bib0032","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1182\/blood.2021014804","article-title":"Conditioning Intensity and Peri-Transplant Flow Cytometric MRD Dynamics in Adult AML","volume":"139","author":"Paras","year":"2022","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jtct.2025.07.012_bib0033","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41409-018-0300-8","article-title":"The significance of peri-transplantation minimal residual disease assessed by multiparameter flow cytometry on outcomes for adult AML patients receiving haploidentical allografts","volume":"54","author":"Liu","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"39","key":"10.1016\/j.jtct.2025.07.012_bib0034","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202400544","article-title":"Distinct immune homeostasis remodeling patterns after HLA-matched and haploidentical transplantation","volume":"11","author":"Guo","year":"2024","journal-title":"Adv Sci"},{"issue":"1","key":"10.1016\/j.jtct.2025.07.012_bib0035","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1038\/s41467-025-58370-9","article-title":"Epigenetic mechanisms controlling human leukemia stem cells and therapy resistance","volume":"16","author":"Takao","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtct.2025.07.012_bib0036","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2024026598","article-title":"Precision medicine for high-risk gene fusions in paediatric AML: a focus on KMT2A, NUP98, and GLIS2 Rearrangements","author":"Egan","year":"2025","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jtct.2025.07.012_bib0037","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1182\/blood.2019003267","article-title":"CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemia","volume":"136","author":"Schmoellerl","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.07.012_bib0038","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2024.287206","article-title":"Prophylactic and pre-emptive donor lymphocyte infusion in patients with acute myeloid leukemia and myelodysplastic syndrome: validation of current recommendations and proposal of a modified outcome assessment","author":"Vel\u00e1zquez","year":"2025","journal-title":"Haematologica"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725013247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725013247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:29:53Z","timestamp":1793496593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725013247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2666636725013247"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.07.012","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NUP98 Rearrangement Dynamics Predict Outcomes in Adult Patients With Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Real-World Study","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}